[1] Klein R, Klein B E. The prevalence of age-related eye diseases and visual impairment in aging:current estimates[J]. Invest Ophthalmol Vis Sci, 2013, 54(14):ORSF5-ORSF13. [2] Penn J S, Tolman B L, Henry M M. Oxygen-induced retinopathy in the rat:relationship of retinal nonperfusion to subsequent neovascularization[J]. Invest Ophthalmol Vis Sci, 1994,35(9):3429-3435. [3] 徐传磊, 陈晓明,徐志勇,等. 建立食蟹猴糖尿病模型的研究[J]. 广州中医药大学学报,2009,26(1):91-94. [4] Jo D H, Cho C S, Kin J H, et al. Animal models of diabetic retinopathy:doors to investigate pathogenesis and potential therapeutics[J]. J Biomed Sci, 2013, 20:38. [5] Islam M S. Animal models of diabetic neuropathy:progress since 1960s[J]. J Diabetes Res, 2013, 2013:149452. [6] 梁斌,吴晓云. 非人灵长类糖尿病动物模型研究进展[J]. 动物学研究,2011, 32(1):91-96. [7] Kim S Y, Johnson M A, Mcleod D S, et al. Retinopathy in monkeys with spontaneous type 2 diabetes[J]. Invest Ophthalmol Vis Sci, 2004,45(12):4543-4553. [8] Johnson M A, LuHy G A, Mcleod D S, et al. Ocular structure and function in an aged monkey with spontaneous diabetes mellitus[J]. Exp Eye Res, 2005,80(1):37-42. [9] Uemura A. Identification of novel drug targets for the treatment of diabetic retinopathy[J]. Diabetes Metab J, 2013, 37(4):217-224. [10] Bowes Rickman C, Farsiu S, Toth C A, et al. Dry age-related macular degeneration:mechanisms, therapeutic targets, and imaging[J]. Invest Ophthalmol Vis Sci, 2013,54(14):ORSF68-ORSF80. [11] Ambati J, Anand A, Fernandez S, et al. An animal model of age-related macular degeneration in senescent Ccl-2-or Ccr-2-deficient mice[J]. Nat Med, 2003, 9(11):1390-1397. [12] Justilien V, Pang J J, Renganathan K, et al. SOD2 knockdown mouse model of early AMD[J]. Invest Ophthalmol Vis Sci, 2007,48(10):4407-4420. [13] Chan C C, Ross R J, Shen D, et al. Ccl2/Cx3cr1-deficient mice:an animal model for age-related macular degeneration[J]. Ophthalmic Res, 2008, 40(3-4):124-128. [14] Klein R, Chou C F, Klein B E, et al. Prevalence of age-related macular degeneration in the US population[J]. Arch Ophthalmol, 2011, 129(1):75-80. |